Clinical Trial

Predictive Values of Presepsin Levels in ASciteS in Patients With Chronic Liver Failure

Study acronym: PASS
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 21, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
The investigators aim to study the predictive value of presepsin in ascites in newly admitted patients with chronic liver failure.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-01-24; most recent amendment 2024-08-20.
Status change: Not Yet Recruiting → Recruiting 2024-05-06
Trial Details
NCT Number NCT06224023
Lead Sponsor Carol Davila University of Medicine and Pharmacy
Conditions Ascites Hepatic, Liver Failure, Cirrhosis, Liver
Enrollment 30 participants
Start Date 2024-08-01
Primary Completion 2024-12-31 (estimated)
Study Completion 2024-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-08-21